Journal • IO biomarker
|
ALK (Anaplastic lymphoma kinase) • TNFRSF8 (TNF Receptor Superfamily Member 8)
|
ALK positive • TNFRSF8 positive • TNFRSF8 expression • ALK negative
|
doxorubicin hydrochloride • cyclophosphamide • Adcetris (brentuximab vedotin) • prednisone